FDA Inspection 868633 — Summit Biosciences Inc.

Summit Biosciences Inc. — FEI 3007577023

The FDA completed an inspection of Summit Biosciences Inc. on February 28, 2014 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Lexington, KY (United States)